If any further evidence were needed for the insatiable investor appetite for companies with obesity assets, look no further than New York start-up Metsera. After emerging from stealth with a $290 ...

Metsera is leaving no fundraising stone unturned as it races to grab a slice of the fast-growing market for obesity drugs, cueing up an IPO.

See the latest Maze Therapeutics Inc stock price (MAZE:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

We will look at the top 10 best 80s logos by design features, cultural significance and how far-reaching these accolades have been up to date.

This article will explore 15 of the most iconic logos ever created. We'll examine what makes them memorable, their history, and their impact.

In this three-part podcast series, “Trial Trailblazers: Behind clinical breakthroughs,” gain rare insight into the human stories driving innovative clinical research. From pioneering treatments for ...